Patient  Information

Get detailed information on each IVF embryo before implantation

WHAT IS ORCHID?
Orchid overview
Orchid provides whole genome embryo screening that combines Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic/Single Gene Defects (PGT-M), and screens for hundreds of genes linked to severe monogenic diseases.

Orchid helps families maximize their chance for a successful pregnancy and healthy baby by screening embryos using whole genome sequencing.
* Percentage is based on validation studies using genomic regions of National Institute of Standards and Technology - GIAB samples
How it works

Get the most extensive reports for your embryos

Sequencing
Your IVF doctor orders Orchid on your behalf. An embryologist sends Orchid’s lab ~5 cells from each embryo, the same amount of material required for standard testing.
Reporting
Our team of experts reviews the genetic data and reports on the information requested for each embryo in your cycle.
Expert review
Meet with a board certified genetic counselor to explain the findings from the report, discuss specific risks related to each embryo tested, and answer any questions.

Ready to get started? Speak with a board certified genetic counselor.

Get access
What People Are Saying
“This is the way to reduce disease and suffering in kids, and is the best thing you can do for your child and yourself. The fact that we have screened for so much gives us peace of mind. Understanding our genetics is a huge advantage.”
Rohan & Jen
Orchid customers
What People Are Saying
“Orchid gave us clarity around the things that we care about, especially our family history 
of conditions. We move forward now with so much more confidence than we would have.”
Kevin & Julia
Orchid customers
What People Are Saying
“We deeply believe in leveraging technology to better our lives. Orchid's groundbreaking technology was a game-changer for us. It provided invaluable insights as we embarked on the path to parenthood.”
Michelle & Tom
Orchid customers
What People Are Saying
We screened our embryos because were at risk for a hereditary cancer. Orchid found something more - we were carriers for the same condition. Without screening, 25% of our children could have the disease. Now, our kids are more likely to be healthy.
Andy & Ella
Orchid customers
What People Are Saying
“When we learned that PGT-WGS was an option we were  onboard. Orchid let us screen our embryos for a range of inherited diseases.  It's exciting that this technology is empowering parents to make informed choices.”
Roshan & Julie
Orchid customers
04
 / 
05

Get whole genome embryo screening

Make an informed decision with more data

FAQs

What genetic variations are included in Orchid’s
report?
While there can be hundreds of genetic variations within an embryo, Orchid only reports on genes known to cause monogenic disease based on decades of research. Genes included on our panels are selected based on extensive literature searches and information from the Clinical Domain Working Group, a group of independent academic geneticists. Only pathogenic and likely pathogenic variants based on the American College of Medical Genetics and Genomics (ACMG) guidelines are included. Carrier status is not reported unless requested.
Who would benefit most from Orchid?
Any patient could benefit from Orchid, but a few examples of patients that would be most interest/benefit:
  • Patients looking to use the most advanced genetic testing option available, or are otherwise concerned about neurodevelopmental disorders, pediatric cancers, and/or birth defects
  • Patients who might traditionally do PGT-M (Orchid does not usually require probe development, which increases speed to results)
  • Patients concerned about de novo variants (i.e., advanced paternal age, a previous child with a de novo variant)
  • Patients using donor egg/sperm/embryos, with potentially limited contact with donor for testing
How much does Orchid cost?
Orchid’s standard Preimplantation Whole-Genome Sequencing costs roughly $12,500 for an IVF cycle with 5 biopsied embryos.  However, costs may vary depending on the clinic and the complexity of a case (additional testing may incur additional costs).  For cost-sensitive patients, options for more limited screening may be available.  For more details please contact genetics@orchidhealth.com.